For personal use only

Size: px
Start display at page:

Download "For personal use only"

Transcription

1 ASX: VRX Diggers & Dealers August 2012 Bruce Maluish, Managing Director 1

2 Disclaimer & Competent Person This presentation was prepared with due care and attention and is current at the date of the presentation. The summary is not an offer or recommendation to purchase or subscribe for securities in Ventnor Resources Limited or to retain any securities currently held. It does not take into account the potential and current individual investment objectives or the financial situation of investors. Actual results may materially vary from any forecasts (where applicable) in this presentation. Before making or varying any investment in securities in Ventnor Resources Limited, all investors should consider the appropriateness of that investment in light of their individual investment objectives and financial situation. The information in this presentation that relates to Exploration Results is based on information compiled by Mr David Reid who is a Member of the Australasian Institute of Mining and Metallurgy (MAusIMM). Mr Reid is an employee of Ventnor Resources Limited. Mr Reid has sufficient experience which is relevant to the style of mineralisation and type of deposit under consideration and to the activity which he is undertaking to qualify as a Competent Person as defined in the 2004 Edition of the Australasian Code for Reporting of Exploration Results, Mineral Resources and Ore Reserves. Mr Reid consents to the inclusion in this presentation the matters based on information provided by him and in the form and context in which it appears. 2

3 Ventnor Resources Projects 3

4 Thaduna / Green Dragon Copper Project Western Australia 4

5 Thaduna/Green Dragon Location 5

6 Ventnor Gascoyne Tenements 6

7 Thaduna/Green Dragon 175 Kms northeast of Meekatharra 4PLs covering 604 Ha 40 kms east of Sandfire Resources De Grussa Significant drilling results from 35,000 metres drilling JORC Resource Q

8 Thaduna Historic mining and production completed 1971 Prior production 30, % Cu Historic drilling % Cu from 80 m First phase April 2011 included: % Cu from 80 m; % Cu from 87 m and % Cu from 75 m. 8

9 Thaduna 9

10 10

11 Thaduna 11

12 Typical Hydrothermal Copper Geology 12

13 Thaduna Second phase July 2011: % Cu from 30 m; % Cu from 121 m; % Cu from 100 m; % Cu from 122 m and % Cu from 100 m. 13

14 Thaduna 14

15 Thaduna Announcement: 24 January 2012 from 3 rd phase drilling % Cu from 111 metres (THRC113) including % Cu from 134 m downhole; % Cu from 125 metres (THRC114) including % Cu from 127 m downhole and ended in mineralisation, 3.70% Cu at EOH, extended by diamond drilling 15

16 Thaduna Copper Geology 16

17 Thaduna Announcement 12 March 2012 THRC119 has been drilled with a diamond tail and encountered significant sulphide mineralisation 14.0 m from m to m down hole Targeting down plunge extension to the main lode Increasing in grade and thickness with depth 17

18 Thaduna THRC metres 18

19 Thaduna THRC metres 19

20 Thaduna Announcement 1 August % Cu (includes % Cu and 29.7 g/t Ag) % Cu % Cu % Cu % Cu % Cu % Cu % Cu % Cu % Cu 20

21 Thaduna 21

22 Thaduna 22

23 Thaduna Long Section 23

24 Thaduna Long Section Inset 24

25 25

26 Chalcopyrite Mineralogy Mineral Name Area Mass % Background C halcopyrite Bornite C ovellite Quartz C hlorite Albite Micas Rutile/Anatase Other minerals Mineral Name Area Mass % Cu mass % Chalcopyrite Bornite Covellite Quartz Chlorite Albite Micas Rutile/Anatase Other minerals Total

27 Thaduna Proposed Mining Infrastructure 27

28 Thaduna 28

29 Green Dragon 29

30 Green Dragon Prior production 9, % Cu Historic drilling % Cu from 97 m First phase drilling April 2011: % Cu from 64 m, % Cu from 44 m, % Cu from 79 m, % Cu from 85 m 30

31 Green Dragon Second phase July 2011: % Cu from 85 m; 2.98% Cu from 44 m; 7.86% Cu from 60 m; 6.07% Cu from 80 m; 5.07% Cu from 64 m and 5.93% Cu from 88 m. 31

32 Green Dragon Third phase November 2011: 6.07% Cu from 80 m; 5.07% Cu from 64 m; 5.93% Cu from 88 m; 10.96% Cu from 37 m and 4.00% Cu from surface. Phase 4 Drilling completed 32

33 Green Dragon 33

34 Green Dragon

35 Thaduna/Green Dragon Project Fourth Phase drilling nears completion JORC Resource Q Preliminary scoping study to follow Many mining permit studies completed Development options to be considered 35

36 Thaduna Proposed Mining Infrastructure New Plant Nearby 36

37 Capital Structure Issued Shares Options Total M 25.4 M Cash on hand $2.9 June 30 Market 50c $37 M 37

First Results Prospector Drilling Program

First Results Prospector Drilling Program 24 June 2008 Manager Company Announcements Company Announcements Office Australian Stock Exchange Limited Level 10, 20 Bond Street SYDNEY NSW 2000 ABN 42 082 593 235 Electronic delivery No of pages: 10

More information

ASX/Media Announcement 24 December 2010

ASX/Media Announcement 24 December 2010 ASX/Media Announcement 24 December 2010 ANDY WELL PROJECT UPDATE Diamond drilling continues to deliver high-grade results RC drilling continues at Wilber Lode to define a JORC Resource Southern extensions

More information

Mutiny continues to hit high grade gold and copper intersections in latest Deflector drilling

Mutiny continues to hit high grade gold and copper intersections in latest Deflector drilling Mutiny continues to hit high grade gold and copper intersections in latest Deflector drilling New Diamond drill results within the Deflector Deposit include: 3.3m @ 79g/t Au and 10.5% Cu from 62m in 12DD042

More information

SCOUT DRILLING COMPLETED ON KELLERBERRIN URANIUM PROJECT

SCOUT DRILLING COMPLETED ON KELLERBERRIN URANIUM PROJECT ASX ANNOUNCEMENT SCOUT DRILLING COMPLETED ON KELLERBERRIN URANIUM PROJECT ASX Code: MDX ABN: 28 106 866 442 Corporate Description Mindax's Mt Forrest Iron Project is progressing through feasibility with

More information

28 April 2017 ASX Code: COY. March 2017 Quarterly Activity Report

28 April 2017 ASX Code: COY. March 2017 Quarterly Activity Report 28 April 2017 ASX Code: COY The following report details the operating and corporate activities of Coppermoly Ltd (Coppermoly or the Company) for the quarter ended 31 March 2017 and to the date of this

More information

Disclaimer. Matrix Metals Limited Presentation October

Disclaimer. Matrix Metals Limited Presentation October Matrix Metals Limited Presentation October 2008 Disclaimer The material used is this presentation is intended to be a summary of selected geological data, current and proposed activities, as well as resource

More information

Riesling Base Metal Project pxrf Soil Geochemistry

Riesling Base Metal Project pxrf Soil Geochemistry pxrf Soil Geochemistry Ken Harvey Non-executive Director Superior Resources Limited Riesling Located 280km NW Townsville & 17km SSW of Mount Surprise, North Queensland VMS (or Broken Hill) type deposit

More information

TRI ORIGIN MINERALS LTD

TRI ORIGIN MINERALS LTD TRI ORIGIN MINERALS LTD Mines And Wines Conference September 2007 Woodlawn Zinc-Copper Projects ASX Code: TRO DISCLAIMER The Information contained in this presentation has been prepared using the information

More information

Kihabe Zn, Pb, Ag Project Botswana

Kihabe Zn, Pb, Ag Project Botswana Kihabe Zn, Pb, Ag Project Botswana 8/800 Albany Highway East Victoria Park, WA 6101 www.mountburgess.com mtb@mountburgess.com ASX: MTB Kihabe 14.4Mt Resource* Nxuu 10.9Mt Resource* * See slide 5 for Resource

More information

For personal use only

For personal use only L1, 254 Railway Parade, West Leederville WA 6007 PO Box 1245, West Leederville WA 6901 T: +61 8 9363 7800 e: office@platypusminerals.com.au www.platypusminerals.com.au ASX/Media Announcement Perth: 18

More information

For personal use only

For personal use only Exploration Office Level 3, 100 Pirie Street ADELAIDE SA 5000 ABN: 96 110 336 733 Tel: +61 8 8232 8320 Fax: +61 8 8232 8811 www.monaxmining.com.au 21 December 2016 Significant Sampling Results at Litchfield

More information

BISIE PROJECT UPDATE

BISIE PROJECT UPDATE Level 3, Gotthardstrasse 20, CH-6300, Zug, Switzerland Tel: +41 41 711 02 81 www.alphaminresources.com BISIE PROJECT UPDATE News Release 2014-10-27 VANCOUVER, CANADA October 27 th, 2014 Alphamin Resources

More information

Accelerated Mining and Gold Production Completion of Strategic Alliance with Territory Resources for Tennant Creek $2m Placement at 56.

Accelerated Mining and Gold Production Completion of Strategic Alliance with Territory Resources for Tennant Creek $2m Placement at 56. ASX Announcement 6 September 2018 ASX: ERM Accelerated Mining and Gold Production Completion of Strategic Alliance with Territory Resources for Tennant Creek $2m Placement at 56.8% premium Highlights Emmerson

More information

For personal use only

For personal use only ASX RELEASE Suite 2501 Level 25 St Martins Tower 31 Market Street Sydney NSW 2000 Australia (PO Box Q638 QVB Market Street NSW 1230 Australia) Tel: +61 (02) 9283 3880 8 October 2018 ASSAY RESULTS RECEIVED

More information

PRELIMINARY DRILLING RESULTS FROM FIVE NEW DRILL HOLES EXTEND IRON MINERALISATION AT MARIELA

PRELIMINARY DRILLING RESULTS FROM FIVE NEW DRILL HOLES EXTEND IRON MINERALISATION AT MARIELA LATIN RESOURCES LIMITED ACN: 131 405 144 Suite 2, Level 1, 254 Rokeby Road Subiaco, Western Australia, 6008. P 08 9485 0601 F 08 9321 6666 E info@latinresources.com.au 30 January 2013 PRELIMINARY DRILLING

More information

DNI Metals - First 12 of 28 Diamond Core Assays Received; Including 34m Grading 5.63% Graphitic Carbon

DNI Metals - First 12 of 28 Diamond Core Assays Received; Including 34m Grading 5.63% Graphitic Carbon DNI Metals - First 12 of 28 Diamond Core Assays Received; Including 34m Grading 5.63% Graphitic Carbon Toronto, Ontario--(Newsfile Corp. - December 7, 2017) - DNI Metals Inc. (DNI: CSE) (FSE: DG7N) (OTC

More information

Star Zinc Project Update Released 07:00 15-Oct-2018

Star Zinc Project Update Released 07:00 15-Oct-2018 Regulatory Story Galileo Resources PLC - GLR Star Zinc Project Update Released 07:00 15-Oct-2018 RNS Number : 9593D Galileo Resources PLC 15 October 2018 For immediate release 15 October 2018 Galileo Resources

More information

January A different kind of Zinc Explorer

January A different kind of Zinc Explorer January 2018 A different kind of Zinc Explorer Cautionary Statement This presentation contains certain statements that may be deemed "forward-looking statements". All statements in this presentation, other

More information

Investor Presentation

Investor Presentation ASX:THC B u i l d i n g a M e d i c i n a l C a n n a b i s B u s i n e s s Investor Presentation November 2017 DISCLAIMER The material in this presentation (material) is not and does not constitute an

More information

Ayawilca Zinc Project Peru: Targeting Resource Growth in 2017

Ayawilca Zinc Project Peru: Targeting Resource Growth in 2017 Ayawilca Zinc Project Peru: Targeting Resource Growth in 2017 PDAC Peru Day Presentation Dr Graham Carman Tinka Resources Limited March 6, 2017 OTC: TKRFF Disclaimer This presentation is not directed to,

More information

ASX/Media Announcement

ASX/Media Announcement L1, 254 Railway Parade, West Leederville WA 6007 PO Box 1245, West Leederville WA 6901 T: +61 8 9363 7800 e: office@platypusminerals.com.au www.platypusminerals.com.au ASX/Media Announcement Perth: 19

More information

White Rose Research Online URL for this paper: Version: Accepted Version

White Rose Research Online URL for this paper:   Version: Accepted Version This is a repository copy of Magmatic Hydrothermal Fluids at the Sedimentary Rock-hosted, Intrusion-related Telfer Gold-Copper Deposit, Paterson Orogen, Western Australia: P-T-X Constraints on the Ore

More information

OPEMISKA COPPER MINE COMPLEX. PORE: TSXV powerore.com

OPEMISKA COPPER MINE COMPLEX. PORE: TSXV powerore.com OPEMISKA COPPER MINE COMPLEX PORE: TSXV powerore.com FORWARD LOOKING STATEMENTS We are in the mineral exploration and development business. It is inherently risky, and all potential investors should be

More information

WONGAN HILLS, W.A. - base metals and gold project

WONGAN HILLS, W.A. - base metals and gold project ASX ANNOUNCEMENT ABN 46 006 045 790 www.cullenresources.com.au ASX Symbol: CUL 3 May 2018 New assays confirm and extend geochemical anomalies WONGAN HILLS, W.A. - base metals and gold project Results of

More information

ASX/Media Announcement

ASX/Media Announcement L1, 254 Railway Parade, West Leederville WA 6007 PO Box 1245, West Leederville WA 6901 T: +61 8 9363 7800 e: office@platypusminerals.com.au www.platypusminerals.com.au ASX/Media Announcement Perth: 21

More information

For personal use only

For personal use only ASX RELEASE (23 rd March 2018) AGM PowerPoint Presentaion In accordance with the requirements of Listing Rule 3.1 we submit the attached material being distributed at the Company s Annual General Meeting

More information

For personal use only

For personal use only Virtus Health (ASX. VRT) Sue Channon CEO and Glenn Powers CFO Navigating Future Growth, UBS Australasian Conference 7 November, 2016 DISCLAIMER 2 The material in this presentation has been prepared by

More information

DELICA D:5 ACTIVE GEAR 0

DELICA D:5 ACTIVE GEAR 0 DELICA D:5 ACTIVE GEAR 0 1 1. FY2017 1Q Results 2. FY2017 1Q Results by Region 3. FY2017 Forecast 4. Initiatives for the Future FY2017 1Q Results Summary (vs. FY2016 1Q) (Apr-Jun 2016) (Apr-Jun 2017) (billion

More information

For personal use only

For personal use only ASX Announcement 12 July 2017 ASX Code: ARM Aurora Minerals Group of Companies Diversified Minerals Exploration via direct and indirect interests Predictive Discovery Limited (ASX: PDI) 39.6% - Gold Exploration

More information

ASX/Media Announcement

ASX/Media Announcement L1, 254 Railway Parade, West Leederville WA 6007 PO Box 1245, West Leederville WA 6901 T: +61 8 9363 7800 e: office@platypusminerals.com.au www.platypusminerals.com.au ASX/Media Announcement Perth: 24

More information

For personal use only

For personal use only ASX/Media Announcement 27th May 2016 SUBSTANTIAL RESOURCE UPGRADE FOR COPI NORTH HEAVY MINERAL SAND DEPOSIT Highlights Copi North Resource tonnage increased by 22% from 11.6 Mt to 14.2 Mt Indicated category

More information

NOXOPHARM CORPORATE PRESENTATION FNN SHAW&PARTNERS INVESTOR EVENT ASX: NOX

NOXOPHARM CORPORATE PRESENTATION FNN SHAW&PARTNERS INVESTOR EVENT ASX: NOX Date: 14 August, 2018 Sydney, Australia ASX: NOX Noxopharm Limited NOXOPHARM CORPORATE PRESENTATION FNN SHAW&PARTNERS INVESTOR EVENT ABN 50 608 966 123 Registered Office and Operations Office: Suite 3,

More information

HISTORICAL OVERVIEW OF GOLD COPPER MINERAL DISCOVERIES & MINE DEVELOPMENTS IN THE PHILIPPINES

HISTORICAL OVERVIEW OF GOLD COPPER MINERAL DISCOVERIES & MINE DEVELOPMENTS IN THE PHILIPPINES 15 10 05 120 125 120 125 15 10 05 HISTORICAL OVERVIEW OF GOLD COPPER MINERAL DISCOVERIES & MINE DEVELOPMENTS IN THE PHILIPPINES Spain China 3rd 1 th century North America Java 16 th 19 th century12 th

More information

For personal use only

For personal use only AusCann Makes Major Progress Towards Production of Cannabinoid Medicines During FY18 Highlights Undertook comprehensive pharmaceutical development project to create an optimal dosage form cannabinoid medicine

More information

Brisa Concessão Rodoviária. 1Q 2017 Traffic Update

Brisa Concessão Rodoviária. 1Q 2017 Traffic Update Brisa Concessão Rodoviária 1Q 2017 Traffic Update 15 th May 2017 Disclaimer The information contained herein ( Information ) has been prepared by Brisa Concessão Rodoviária, S.A. ("BCR") and which, according

More information

Lao People s Democratic Republic

Lao People s Democratic Republic Authentic in Lao Only Lao People s Democratic Republic Peace Independence Democracy Unity Prosperity Ministry of Mines and Energy Ref. 1116/MEM Vientiane Capital, dated 21.09.2010 Regulation on Sending

More information

Improving the lives of people with neurological conditions. Annual General Meeting Neurotech International Limited (ASX: NTI) November 2017

Improving the lives of people with neurological conditions. Annual General Meeting Neurotech International Limited (ASX: NTI) November 2017 Improving the lives of people with neurological conditions Annual General Meeting Neurotech International Limited (ASX: NTI) November 2017 Neurotech Overview Medical device company, focussed on the development

More information

Expanding Resources in the Caribbean

Expanding Resources in the Caribbean TSX.V: UGD Expanding Resources in the Caribbean CORPORATE PRESENTATION; September 2017 Forward Looking Statements Certain statements contained in this presentation, including statements regarding events

More information

TSX: LUN OMX: LUMI Corpora Corpor t a e t Presen esen a t tion

TSX: LUN OMX: LUMI Corpora Corpor t a e t Presen esen a t tion TSX: LUN OMX: LUMI Corporate Presentation November 2013 Cautionary Statements Caution Regarding Forward Looking Statements This presentation contains forward looking statements. These forward looking statements

More information

Acquisition of BP s Interests in Bruce, Keith and Rhum Fields in the North Sea Frequently Asked Questions

Acquisition of BP s Interests in Bruce, Keith and Rhum Fields in the North Sea Frequently Asked Questions Acquisition of BP s Interests in Bruce, Keith and Rhum Fields in the North Sea Frequently Asked Questions 1. What is Serica buying? Serica Energy is buying the Bruce, Keith and Rhum (BKR) package of assets

More information

Spiros Nomikos Chief Executive Officer Solvay Sodi Bulgaria

Spiros Nomikos Chief Executive Officer Solvay Sodi Bulgaria Spiros Nomikos Chief Executive Officer Solvay Sodi Bulgaria FINANCIAL TIMES INVESTING IN BULGARIA CONFERENCE Investment Opportunities in Bulgaria The Case of Solvay Sodi Spiros Nomikos CEO of Solvay Sodi

More information

For personal use only

For personal use only ASX ANNOUNCEMENT 22 NOVEMBER 2017 AGM ADDRESSES FROM THE CHAIRMAN & CEO 22 November 2017 Cann Group Limited (ASX: CAN) is pleased to provide the following addresses to be delivered by its Chairman Allan

More information

Global Influenza Vaccine Market: Industry Analysis & Outlook

Global Influenza Vaccine Market: Industry Analysis & Outlook Industry Research by Koncept Analytics Global Influenza Vaccine Market: Industry Analysis & Outlook ----------------------------------------- January 2017 1 Executive Summary Influenza, also known as flu,

More information

Shareholder Presentation Annual Meeting 2018

Shareholder Presentation Annual Meeting 2018 Shareholder Presentation Annual Meeting 2018 FY 18 HIGHLIGHTS Strong sales growth of 2 nd Gen TruScreen to China commenced during 4 th quarter. (50% of the year s sales were generated in the fourth quarter)

More information

ASX Investor Presentation

ASX Investor Presentation ASX Investor Presentation Sydney, Australia Dr Peter Neustadt Executive Chairman and CEO November 2014 Copyright and registered trademark notice ASX Investor Presentation Page 0 Who we are SomnoMed Limited

More information

Investor presentation. Bioshares Biotech Summit July 2017

Investor presentation. Bioshares Biotech Summit July 2017 Investor presentation Bioshares Biotech Summit 2017 22 July 2017 1 Disclaimer Some of the information in this presentation may refer to Dimerix Limited ( Dimerix or the Company ) based on information available

More information

For personal use only

For personal use only A.B.N. 52 007 626 575 20 November 2017 ASX:JRV NICO YOUNG COBALT-NICKEL LATERITE: UPDATED MINERAL RESOURCE HIGHLIGHTS JORC Inferred resource of 167.8Mt @ 0.59% Ni and 0.06% Co (using a 0.6% Ni equivalent

More information

Effects of enhanced pyrite on the Galvanox process

Effects of enhanced pyrite on the Galvanox process Effects of enhanced pyrite on the Galvanox process Ghazaleh Nazari Supervisors: Dr. Dixon and Dr. Dreisinger The University of British Columbia Outline Chalcopyrite Leaching The Galvanox Process Motivations

More information

Developing Xanamem for Alzheimer s Dementia

Developing Xanamem for Alzheimer s Dementia Developing Xanamem for Alzheimer s Dementia Dr. Bill Ketelbey CEO, Actinogen Medical Investor Presentation March 2015 Forward Statements This presentation has been prepared by Actinogen Limited. ( Actinogen

More information

Corporate Presentation January 2019

Corporate Presentation January 2019 TSXV & BVL:TK OTCPK: TKRFF www.tinkaresources.com Corporate Presentation January 2019 Disclaimer This presentation is not directed to, or intended for distribution to or use by, any person or entity that

More information

Macmillan Pass Zinc Project: Growing an Already World-Class Asset

Macmillan Pass Zinc Project: Growing an Already World-Class Asset Macmillan Pass Zinc Project: Growing an Already World-Class Asset January 2018 Cautionary Statements The following statements are required by Canadian securities legislation: Forward-Looking Statements:

More information

Tamsulosin Hydrochloride 0.4 mg Capsule

Tamsulosin Hydrochloride 0.4 mg Capsule Tamsulosin Hydrochloride 0.4 mg Capsule, Tamsulosin Hydrochloride 0.4 mg Capsule India, Tamsulosin Hydrochloride 0.4 mg Capsule manufacturers India, side effects Tamsulosin Hydrochloride 0.4 mg Capsule

More information

Investment in MGC Pharmaceuticals

Investment in MGC Pharmaceuticals Investment in MGC Pharmaceuticals Investor Presentation May 2015 Disclaimer This presentation has been prepared by Erin Resources Limited ( Company ). It does not purport to contain all the information

More information

AFFIN HOLDINGS BERHAD (Company No.: W) (Incorporated in Malaysia under the Companies Act, 2016) NOTICE TO SHAREHOLDERS IN RELATION TO THE

AFFIN HOLDINGS BERHAD (Company No.: W) (Incorporated in Malaysia under the Companies Act, 2016) NOTICE TO SHAREHOLDERS IN RELATION TO THE THIS NOTICE IS FOR YOUR INFORMATION ONLY. YOU ARE NOT REQUIRED TO TAKE ANY ACTION. Bursa Malaysia Securities Berhad ( Bursa Securities ) takes no responsibility for the contents of this Notice, makes no

More information

DMX-200 for Diabetic Kidney Disease

DMX-200 for Diabetic Kidney Disease DMX-200 for Diabetic Kidney Disease A/Prof David Packham MBBS(Hons), FRCP, FRACP, ARCP, MD Chief Medical Officer, Dimerix Nephrologist Bioshares Summit Queenstown, New Zealand 27 July 2018 Disclaimer Some

More information

Itamar Medical. December Investors Presentation.

Itamar Medical. December Investors Presentation. Itamar Medical December 2017. Investors Presentation. Disclaimer Itamar Medical Ltd. (the "Company") is furnishing this presentation and any information given during this presentation, solely for the consideration

More information

Assessment Report on Geochemical Work On The Following Claims

Assessment Report on Geochemical Work On The Following Claims Assessment Report on Geochemical Work On The Following Claims Solid Gold 521566 Merrit High Grade Gold...545405 Iota 2 548002 Iota 548003 Merrit High Grade Ext 549081 PezimGold 562134 Iota 3 565569 Iota

More information

PROACTIVE INVESTOR PRESENTATION

PROACTIVE INVESTOR PRESENTATION www.thcl.com.au ASX RELEASE (16 th May 2017) PROACTIVE INVESTOR PRESENTATION The Hydroponics Company Limited (ASX: THC) is pleased to advise that Dr Andrew Beehag, Chief Executive Officer of Canndeo Limited,

More information

GF China Commodities Weekly

GF China Commodities Weekly GF China Commodities Weekly CHINA ZINC CONCENTRATE SUPPLY WILL BE MORE DEPENDENT ON DOMESTIC MARKETIN 2H16 GFF Commodities Research Contacts : Bonnie Liu;852-3719 1155;bonnieliu@gfgroup.com.hk Zhang Ruoyi;020-85594189;zhangruoyi@gf.com.cn

More information

HARRISBURG UNIVERSITY PROJECT LEADERSHIP FORUM- CASE STUDY. Supporting the Marcellus Shale Boom

HARRISBURG UNIVERSITY PROJECT LEADERSHIP FORUM- CASE STUDY. Supporting the Marcellus Shale Boom HARRISBURG UNIVERSITY PROJECT LEADERSHIP FORUM- CASE STUDY Supporting the Marcellus Shale Boom Marc Reeves, P.G. May 6, 2011 Outline Intro to SAIC Basics on the Marcellus Shale Natural gas demand Nationwide

More information

NOXOPHARM POSTS CORPORATE PRESENTATION AHEAD OF CONFERENCE ASX: NOX. Presentation at Singapore Investor Conference Review of first year of operation

NOXOPHARM POSTS CORPORATE PRESENTATION AHEAD OF CONFERENCE ASX: NOX. Presentation at Singapore Investor Conference Review of first year of operation Date 8 August 2017 Sydney, Australia ASX: NOX Noxopharm Limited ABN 50 608 966 123 Registered Office: Suite 1 Level 6 50 Queen St Melbourne VIC 3000 Australia Operations Office: Suite 3 Level 4 828 Pacific

More information

Akie & Kechika Regional Projects. Akie Project: Zn Pb Ag Cardiac Creek Deposit Advanced Exploration

Akie & Kechika Regional Projects. Akie Project: Zn Pb Ag Cardiac Creek Deposit Advanced Exploration Akie & Kechika Regional Projects Akie Project: Zn Pb Ag Cardiac Creek Deposit Advanced Exploration May 2018 1 Legal Disclaimer This presentation contains forward looking statements; including in particular,

More information

Appendix A Population Projection Study

Appendix A Population Projection Study Westhope Comprehensive Plan Appendix A Population Projection Study 48 K 3 W Keith Witwer & Associates Helping your community plan for the future February 27, 2012 Westhope, North Dakota Population Study

More information

MYOS RENS Technology CEO Joseph Mannello Issues Letter to Shareholders

MYOS RENS Technology CEO Joseph Mannello Issues Letter to Shareholders December 14, 2018 MYOS RENS Technology CEO Joseph Mannello Issues Letter to Shareholders CEDAR KNOLLS, N.J., Dec. 14, 2018 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS),

More information

Transforming IVF and Biological Separations Presentation by Executive Chairman, Alison Coutts

Transforming IVF and Biological Separations Presentation by Executive Chairman, Alison Coutts Transforming IVF and Biological Separations Presentation by Executive Chairman, Alison Coutts NuSep (ASX:NSP) key facts No. shares 237,606,002 Market Cap. $7.1 million (@3 cps) No. of shareholders Approx.

More information

Global Insulin Pump Market with Focus on United States: Industry Analysis & Outlook ( )

Global Insulin Pump Market with Focus on United States: Industry Analysis & Outlook ( ) Industry Research by Koncept Analytics Global Insulin Pump Market with Focus on United States: Industry Analysis & Outlook ----------------------------------------- (2018-2022) January 2019 1 Executive

More information

Putting ALK on the right growth trajectory

Putting ALK on the right growth trajectory Putting ALK on the right growth trajectory Økonomisk Ugebrevs Kapitalmarkedseftermiddag 15. marts 2018 Per Plotnikof, VP Corporate Communications and IR Marts 2018 Allergy: a global disease with a large

More information

DARA Reports Year-End 2012 Financial Results

DARA Reports Year-End 2012 Financial Results April 1, 2013 DARA Reports Year-End 2012 Financial Results Company Provides a Commercial Portfolio and Development Pipeline Business Update RALEIGH, NC -- (MARKETWIRE) -- 04/01/13 -- DARA BioSciences,

More information

For personal use only

For personal use only Australian Securities Exchange Limited Companies Announcements Office SYDNEY 4 April, 2012 New Australian Drug Developer Lists on ASX Key points Growth-focused Australian drug and therapeutic development

More information

Not an Offer for Securities

Not an Offer for Securities Not an Offer for Securities This presentation has been prepared by REVA Medical, Inc. (REVA or the Company) solely for its use at presentations to be made by the Company. This presentation does not constitute

More information

Pressure acid leaching of zinc sulfide concentrate

Pressure acid leaching of zinc sulfide concentrate Pressure acid leaching of zinc sulfide concentrate GU Yan( ), ZHANG Ting-an( ), LIU Yan( ), MU Wang-zhong( ), ZHANG Wei-guang( ) DOU Zhi-he( ), JIANG Xiao-li( ) Key Laboratory of Ecological Utilization

More information

For personal use only

For personal use only October 29 th, 2018 RotoGro to Acquire 100% of Canadian Lawful Cannabis License RotoGro to acquire 100% of the issued share capital of Supra THC from Valens GroWorks Corp. ( CSE:VGW ) Supra THC holds a

More information

Universal Biosensors, Inc.

Universal Biosensors, Inc. Universal Biosensors, Inc. ARBN 121 559 993 Buchan Three Tickers Presentation 18 th September 2013 1 Important Disclaimer This presentation is intended to provide a general outline only and is not intended

More information

Mental Toronto Hydro

Mental Toronto Hydro Mental Health @ Shirley Powell, Director, HR Planning, Systems & Rewards Benefits Canada s 2015 Healthy Outcomes Conference June 9-11, 2015 Niagara-on-the-Lake Company Overview Established in 1911 Largest

More information

SMARTPAY HOLDINGS LIMITED ANNUAL MEETING WEDNESDAY 26 SEPTEMBER 2017

SMARTPAY HOLDINGS LIMITED ANNUAL MEETING WEDNESDAY 26 SEPTEMBER 2017 SMARTPAY HOLDINGS LIMITED ANNUAL MEETING WEDNESDAY 26 SEPTEMBER 2017 Chair s Introduction Welcome Good morning and welcome to Smartpay s Annual Meeting for 2017. I m pleased to be speaking on behalf of

More information

WntResearch. Pearls on a string. 3 September 2018 PRICE EXPECTATIONS INVESTMENT CASE PRICE TRIGGERS PRICE 12 MONTHS COMPANY PROFILE

WntResearch. Pearls on a string. 3 September 2018 PRICE EXPECTATIONS INVESTMENT CASE PRICE TRIGGERS PRICE 12 MONTHS COMPANY PROFILE Occasion: Company announcements +32% +58% Pearls on a string has had troublesome times, but now everything seems to fall into place. With a new CEO in charge the phase II trials close to commencing in

More information

Company overview. Highlights for the 1 st quarter 2018 (January-March)

Company overview. Highlights for the 1 st quarter 2018 (January-March) Company overview Vaccibody is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies. The company is a leader in the rapidly developing field of

More information

Prima Biomed Ltd ASX CODE: PRR. Buy. Australian Biotech with Phase II/III Cancer Vaccine - Investment Summary. Action and Recommendation

Prima Biomed Ltd ASX CODE: PRR. Buy. Australian Biotech with Phase II/III Cancer Vaccine - Investment Summary. Action and Recommendation 29 January 2013 ASX CODE: PRR Buy Prima Biomed Ltd Australian Biotech with Phase II/III Cancer Vaccine - Investment Summary Capital Structure Sector Healthcare Share Price (A$) A$0.105 Target Price A$0.27

More information

XanADu: A Phase II trial of Xanamem TM in mild Alzheimer's disease

XanADu: A Phase II trial of Xanamem TM in mild Alzheimer's disease XanADu: A Phase II trial of Xanamem TM in mild Alzheimer's disease Dr Bill Ketelbey CEO 17TH ALZHEIMER'S AUSTRALIA BIENNIAL NATIONAL DEMENTIA CONFERENCE 19 OCTOBER 2017 Disclaimer This presentation has

More information

Investor Presentation Post-Interim Results Update. September 2011

Investor Presentation Post-Interim Results Update. September 2011 Investor Presentation Post-Interim Results Update September 2011 Disclaimer This presentation contains general information about the company s activities current as at 2 September 2011. It is provided

More information

A Zinc Play With A Bright Future. Corporate Presentation CSE: PSE FSE: PNX

A Zinc Play With A Bright Future. Corporate Presentation CSE: PSE FSE: PNX A Zinc Play With A Bright Future Corporate Presentation CSE: PSE FSE: PNX Disclaimer The information contained in this presentation is provided by Pasinex Resources Limited. ( Pasinex ) for informational

More information

BIOTRON TO PRESENT AT AUSTRALIA BIOTECH INVEST 2013

BIOTRON TO PRESENT AT AUSTRALIA BIOTECH INVEST 2013 Level 2, 66 Hunter Street Sydney NSW 2000 Tel: (61-2) 9300 3344 Fax: (61-2) 9221 6333 E-mail: pnightingale@biotron.com.au Website: www.biotron.com.au 28 October 2013 The Manager Companies ASX Limited 20

More information

Global Spine Market with Focus on Spinal Fusion: Industry Analysis & Outlook ( )

Global Spine Market with Focus on Spinal Fusion: Industry Analysis & Outlook ( ) Industry Research by Koncept Analytics Global Spine Market with Focus on Spinal Fusion: Industry Analysis & Outlook ----------------------------------------- (2016-2020) December 2016 1 Executive Summary

More information

PORTFOLIO UNIT COST (C$) BOOK VALUE (C$) PRICE UNITS MARKET VALUE (C$) MFABC SHORT TRM BOND ,265, ,926, ,265,266.

PORTFOLIO UNIT COST (C$) BOOK VALUE (C$) PRICE UNITS MARKET VALUE (C$) MFABC SHORT TRM BOND ,265, ,926, ,265,266. ACCOUNT STATEMENT CITY OF WEST VANCOUVER September 30, 2015 Account #: 200000196-20 Cross-reference #: 875-1 Account Type: Non-Registered ACCOUNT SUMMARY AS OF SEPTEMBER 30, 2015 PORTFOLIO UNIT COST (C$)

More information

For personal use only

For personal use only Total Face Group Level 4, Bank House 11 19 Bank Place Melbourne 3000 www.totalfacegroup.com.au TOTAL FACE GROUP LTD 17th March 2016 Australian Securities Exchange Company Announcement Office Stock Exchange

More information

Newron announces 2018 financial results and provides outlook for 2019

Newron announces 2018 financial results and provides outlook for 2019 Newron announces 2018 financial results and provides outlook for 2019 Milan, Italy, March 5, 2019 Newron Pharmaceuticals S.p.A. ( Newron ), a biopharmaceutical company focused on the development of novel

More information

Advancing Pancreatic & Liver Cancer Treatment

Advancing Pancreatic & Liver Cancer Treatment ASX.OSL Advancing Pancreatic & Liver Cancer Treatment Australian Biotech Invest 2017 October 24 th Melbourne 1 Important notice This Presentation has been prepared by Ltd (ASX:OSL) (OncoSil or the Company)

More information

PLEO-CMT Top-line Results. Presentation October 16, 2018

PLEO-CMT Top-line Results. Presentation October 16, 2018 PLEO-CMT Top-line Results Presentation October 16, 2018 Disclaimer References herein to this presentation (the Presentation ) shall mean and include this document, any oral presentation accompanying this

More information

Third-quarter results 2013

Third-quarter results 2013 Third-quarter results 213 Fornebu, 6 November 213 Øyvind Eriksen and Leif Borge Agenda 213 Introduction Øyvind Eriksen Executive chairman Financials Leif Borge President & CFO Q&A Q&A session Øyvind Eriksen

More information

Aerpio Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

Aerpio Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update Aerpio Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update TIME-2b Clinical Trial of AKB-9778 in Patients with Diabetic Retinopathy Remains on Track Conference Call

More information

2018: Growing & De-risking the Ayawilca Zinc Project in Peru

2018: Growing & De-risking the Ayawilca Zinc Project in Peru TSXV & BVL:TK OTCPK: TKRFF www.tinkaresources.com 2018: Growing & De-risking the Ayawilca Zinc Project in Peru Corporate Presentation May 2018 Disclaimer This presentation is not directed to, or intended

More information

NewLink Genetics Corporation Provides Operational Update and Reports Second Quarter 2015 Financial Results

NewLink Genetics Corporation Provides Operational Update and Reports Second Quarter 2015 Financial Results July 31, 2015 NewLink Genetics Corporation Provides Operational Update and Reports Second Quarter 2015 Financial Results -Management to Host Conference Call Today at 8:30 a.m. ET- AMES, Iowa, July 31,

More information

A leading, global cannabis business. Investor Presentation

A leading, global cannabis business. Investor Presentation ASX:THC A leading, global cannabis business Investor Presentation March 2017 DISCLAIMER The material in this presentation (material) is not and does not constitute an offer, invitation or recommendation

More information

A Novel Dual-Opioid for Moderate to Severe Pain Management. May 2010

A Novel Dual-Opioid for Moderate to Severe Pain Management. May 2010 MoxDuo A Novel Dual-Opioid for Moderate to Severe Pain Management May 2010 Disclaimer This presentation, including information contained in this disclaimer, is given to you in strict confidence. By attending

More information

RULES OF CONDUCT OF INSIDERS RESPECTING

RULES OF CONDUCT OF INSIDERS RESPECTING T RULES OF CONDUCT OF INSIDERS RESPECTING RADING O F SECURITIES OF TFI International lnc. Amended and restated July 2015 Executive Summary As an insider of TFI International Inc. ( TFI International )

More information

Sprott Investment Conference July 17-20, Booth 6

Sprott Investment Conference July 17-20, Booth 6 Sprott Investment Conference July 17-20, 2018 Booth 6 Forward Looking Statements This presentation contains forward-looking information that involves substantial known and unknown risks and uncertainties,

More information

Nitrazepam. Nitrazepam Tablets TAJ GROUP PHARMACEUTICAL B U S I N E S S. Generics. Active Ingredients: Each tablet contains 10 mg Nitrazepam

Nitrazepam. Nitrazepam Tablets TAJ GROUP PHARMACEUTICAL B U S I N E S S. Generics. Active Ingredients: Each tablet contains 10 mg Nitrazepam Nitrazepam, Nitrazepam India, Nitrazepam manufacturers India, side effects Nitrazepam manufacturers, Taj Pharma India, Nitrazepam overdose, Nitrazepam drug, Nitrazepam composition, Manufacturing Pharmaceutical,

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks Small-Cap Research Sponsored Impartial - Comprehensive August 29, 2018 David Bautz, PhD 312-265-9471 dbautz@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Opiant Pharmaceuticals,

More information

Gert Heylen Head of Genk Plant

Gert Heylen Head of Genk Plant Site visit 07 Genk plant June 7 th, 07 Bernard Hallemans Chief Operating Officer Europe Gert Heylen Head of Genk Plant Disclaimer Forward-Looking Statements This document may contain forward-looking information

More information